These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 27223062)
1. Reactivation of Smac-mediated apoptosis in chronic lymphocytic leukemia cells: mechanistic studies of Smac mimetic. Balakrishnan K; Fu M; Onida F; Wierda WG; Keating MJ; Gandhi V Oncotarget; 2016 Jun; 7(26):39458-39472. PubMed ID: 27223062 [TBL] [Abstract][Full Text] [Related]
2. Structural insight into inhibitor of apoptosis proteins recognition by a potent divalent smac-mimetic. Cossu F; Milani M; Vachette P; Malvezzi F; Grassi S; Lecis D; Delia D; Drago C; Seneci P; Bolognesi M; Mastrangelo E PLoS One; 2012; 7(11):e49527. PubMed ID: 23166698 [TBL] [Abstract][Full Text] [Related]
3. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells. Bockbrader KM; Tan M; Sun Y Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155 [TBL] [Abstract][Full Text] [Related]
4. Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs. Corti A; Milani M; Lecis D; Seneci P; de Rosa M; Mastrangelo E; Cossu F FEBS J; 2018 Sep; 285(17):3286-3298. PubMed ID: 30055105 [TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic significance of the inhibitor of apoptosis protein (IAP) family and its antagonists in chronic lymphocytic leukaemia. Grzybowska-Izydorczyk O; Cebula B; Robak T; Smolewski P Eur J Cancer; 2010 Mar; 46(4):800-10. PubMed ID: 20045309 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs. Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540 [TBL] [Abstract][Full Text] [Related]
7. Structural basis for bivalent Smac-mimetics recognition in the IAP protein family. Cossu F; Milani M; Mastrangelo E; Vachette P; Servida F; Lecis D; Canevari G; Delia D; Drago C; Rizzo V; Manzoni L; Seneci P; Scolastico C; Bolognesi M J Mol Biol; 2009 Sep; 392(3):630-44. PubMed ID: 19393243 [TBL] [Abstract][Full Text] [Related]
9. CLL cells are resistant to smac mimetics because of an inability to form a ripoptosome complex. Maas C; Tromp JM; van Laar J; Thijssen R; Elias JA; Malara A; Krippner-Heidenreich A; Silke J; van Oers MH; Eldering E Cell Death Dis; 2013 Aug; 4(8):e782. PubMed ID: 23990022 [TBL] [Abstract][Full Text] [Related]
10. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP. Vucic D; Franklin MC; Wallweber HJ; Das K; Eckelman BP; Shin H; Elliott LO; Kadkhodayan S; Deshayes K; Salvesen GS; Fairbrother WJ Biochem J; 2005 Jan; 385(Pt 1):11-20. PubMed ID: 15485396 [TBL] [Abstract][Full Text] [Related]
11. Recognition of Smac-mimetic compounds by the BIR domain of cIAP1. Cossu F; Malvezzi F; Canevari G; Mastrangelo E; Lecis D; Delia D; Seneci P; Scolastico C; Bolognesi M; Milani M Protein Sci; 2010 Dec; 19(12):2418-29. PubMed ID: 20954235 [TBL] [Abstract][Full Text] [Related]
12. A dimeric Smac/diablo peptide directly relieves caspase-3 inhibition by XIAP. Dynamic and cooperative regulation of XIAP by Smac/Diablo. Gao Z; Tian Y; Wang J; Yin Q; Wu H; Li YM; Jiang X J Biol Chem; 2007 Oct; 282(42):30718-27. PubMed ID: 17724022 [TBL] [Abstract][Full Text] [Related]
13. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism. Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169 [TBL] [Abstract][Full Text] [Related]
14. X-linked inhibitor of apoptosis functions as ubiquitin ligase toward mature caspase-9 and cytosolic Smac/DIABLO. Morizane Y; Honda R; Fukami K; Yasuda H J Biochem; 2005 Feb; 137(2):125-32. PubMed ID: 15749826 [TBL] [Abstract][Full Text] [Related]
15. Requirement of both the second and third BIR domains for the relief of X-linked inhibitor of apoptosis protein (XIAP)-mediated caspase inhibition by Smac. Huang Y; Rich RL; Myszka DG; Wu H J Biol Chem; 2003 Dec; 278(49):49517-22. PubMed ID: 14512414 [TBL] [Abstract][Full Text] [Related]
16. Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis. Servida F; Lecis D; Scavullo C; Drago C; Seneci P; Carlo-Stella C; Manzoni L; Polli E; Lambertenghi Deliliers G; Delia D; Onida F Invest New Drugs; 2011 Dec; 29(6):1264-75. PubMed ID: 20614162 [TBL] [Abstract][Full Text] [Related]
17. Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2. Cossu F; Mastrangelo E; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Seneci P; Scolastico C; Bolognesi M Biochem Biophys Res Commun; 2009 Jan; 378(2):162-7. PubMed ID: 18992220 [TBL] [Abstract][Full Text] [Related]
18. Solid phase synthesis of Smac/DIABLO-derived peptides using a 'Safety-Catch' resin: identification of potent XIAP BIR3 antagonists. Elsawy MA; Martin L; Tikhonova IG; Walker B Bioorg Med Chem; 2013 Sep; 21(17):5004-11. PubMed ID: 23886811 [TBL] [Abstract][Full Text] [Related]
19. SMAC-expression in denervated human skeletal muscle as a potential inhibitor of coexpressed inhibitor-of-apoptosis proteins. Tews DS; Behrhof W; Schindler S Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):66-70. PubMed ID: 18091317 [TBL] [Abstract][Full Text] [Related]
20. A novel paradigm to trigger apoptosis in chronic lymphocytic leukemia. Loeder S; Zenz T; Schnaiter A; Mertens D; Winkler D; Döhner H; Debatin KM; Stilgenbauer S; Fulda S Cancer Res; 2009 Dec; 69(23):8977-86. PubMed ID: 19920200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]